Extracted from this filing and checked against the source text.
Auditor Changes
SEC 8-K Item 4.01/4.02
confidence 0.9
Vicarious Surgical Inc. dismissed Deloitte & Touche LLP as its auditor.
- Action
- dismissal
- Auditor
- Deloitte & Touche LLP
- Successor
- Cherry Bekaert LLP
Exact text from the filing
On July 7, 2025, the Company dismissed Deloitte & Touche LLP ("Deloitte") as the Company’s independent registered public accounting firm.
View on SEC.gov
Auditor Changes
SEC 8-K Item 4.01/4.02
confidence 0.9
Vicarious Surgical Inc. engaged Cherry Bekaert LLP as its auditor.
- Action
- engagement
- Auditor
- Cherry Bekaert LLP
Exact text from the filing
On July 7, 2025, in connection with the Company’s dismissal of Deloitte, the Audit Committee approved the engagement of Cherry Bekaert as its new independent registered public accounting firm
View on SEC.gov
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.95
Vicarious Surgical Inc. received a nyse noncompliance notice notice regarding market value (rules 802.01B).
- Exchange
- nyse
- Notice
- noncompliance notice
- Deficiency
- market value
- Rules
- 802.01B
Exact text from the filing
April 10, 2025, Vicarious Surgical Inc. (the “Company”) received a written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) indicating the Company was no longer in compliance with the NYSE’s continued listing standards set forth in Section 802.01B of the NYSE’s Listed Company Manual (the “Minimum Market Capitalization Standard”) due to the fact that the Company’s average global market capitalization over a consecutive 30 trading-day period was less than $50 million and, at the same time, its stockholders’ equity was less than $50 million. In accordance with applicable NYSE p
View on SEC.gov